Despite the enormous steps that have been taken towards better understanding of central nervous system (CNS) diseases, healthcare systems worldwide face an unprecedented challenge in dealing with the unmet needs associated with neuropsychiatric disorders. CNS diseases, and mental health disorders are one of the major health challenges of the 21st century, especially in light of an aging population (Race et al., 2013).
SCOPE’s CNS / neurology team is here to help your clinical development program flourish with innovative recruitment strategies, strong site networks and local standard of care knowledge across an array of neurological disorder conditions. Our dedicated CNS project managers combine best practice and up-to-date knowledge of the relevant rating instruments in neurologic and psychiatric study development, in addition to strong local and global regulatory insight.
SCOPE`s team has conducted a variety of CNS studies across diverse major etiologies. With a full range of services and profound experience, we can define a strong development plan for your drug, device, or combination product and oversee the study from conception to delivery of the final report. We have successfully conducted more than 31 studies in neurology involving more than 1,100 clinical sites and 6,500 patients in both adult and pediatric indications. SCOPE has established networks of investigators across different CNS indications, by maintaining close relationships with neurologists, psychiatrists, pain/palliative specialists, and key opinion leaders.
We are able to provide rapid and accurate feasibility estimates at the outset. We build upon our long-term relations with experienced, qualified, and motivated sites to deliver your trial. From identifying the best sites, recruiting the right patients, to assuring assessments are properly completed by trained personnel, SCOPE can meet challenges and targets across a wide range of study designs and hard to recruit indications in CNS. Your program will be monitored by experienced clinical research associates, project managers, medical monitors, and scientists who are familiar with the specific nuances, pitfalls, and opportunities in these types of studies.
CNS trials rely on subjective endpoints, making the selection of appropriate psychometric instruments critical for demonstrating efficacy. Our team advises on guideline-conforming tools and ensures consistency through standardization and rater training.
To reduce patient burden, we prioritize technology-driven data collection, including e-PRO instruments, smartphone apps, and tablets. SCOPE collaborates with selected eCOA providers, and our monitors support study coordinators in training patients for accurate, timely data capture. Our experienced project managers proactively identify study risks, while continuous site communication ensures training, assessment, and data quality across all trial centers.
We support projects focusing on conditions such as hypertension, myocardial infarction, and pulmonary arterial hypertension – all high-impact topics in cardiovascular care and research.
Our experience spans across immune-related areas like allergies and vaccinations – key therapeutic fields with growing relevance.
We help communicate complex topics in metabolic disorders, including type 1 diabetes, where patient education and clarity are crucial.
From Non-Hodgkin lymphoma to various solid tumors – such as bladder, breast, colorectal, or prostate cancer – we bring clarity to oncology and hematology communication.
We develop content for dental indications such as periodontitis, caries prevention, oral mucositis, and temporomandibular disorders – always with precision and sensitivity.
We work on indications like alopecia areata, hypertrophic scars, and psoriasis – conditions that often impact both physical and emotional wellbeing.
Our projects cover topics such as diabetes, hormonal imbalances, and metabolic disorders – essential areas in endocrinology.
From Crohn’s disease and ulcerative colitis to irritable bowel syndrome and reflux – we translate complex GI conditions into clear communication.
We support education and awareness campaigns on hepatitis B and C, liver fibrosis, non-alcoholic fatty liver disease (NAFLD), and cirrhosis – all major topics in liver health.
Conditions like rheumatoid arthritis and polymyalgia rheumatica require nuanced and evidence-based communication – a strength we bring to every campaign.
Whether it’s conjunctivitis or retinopathy – we create accessible content for eye disorders aimed at both professionals and patients.
Rare diseases like idiopathic sudden sensorineural hearing loss demand tailored, precise messaging – we’re here to deliver just that.
We support communication around orthopedic topics such as cartilage defects and osteoarthritis – with a focus on clarity and empathy.
From sudden hearing loss and rhinitis to rare conditions like Schwannomas – we bring ENT topics to life with targeted messaging.
We cover a range of urological topics – from bladder and prostate cancer to bladder pain syndrome and kidney cancer – always with scientific accuracy and approachability.
Our work includes vaccine communication for Hepatitis B, influenza, rabies, and tuberculosis – complex topics made clear and compliant.